Search for Clinical Trial Results
Sarcoma, Alveolar Soft Part - 20 Studies Found
Status | Study |
Completed |
Study Name: Phase 2 Study in Patients With MiT Tumors Condition:
|
Active, not recruiting |
Study Name: Trial of Dasatinib in Advanced Sarcomas Condition:
|
Not yet recruiting |
Study Name: Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors Condition:
Date: 2016-08-15 Interventions: |
Not yet recruiting |
Study Name: Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma Condition:
Interventions: |
Recruiting |
Study Name: CREATE: Cross-tumoral Phase 2 With Crizotinib Condition:
|
Recruiting |
Study Name: Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Condition:
|
Recruiting |
Study Name: Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma Condition:
Interventions: |
Completed |
Study Name: Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma Condition:
Interventions: |
Completed |
Study Name: Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma Condition:
Interventions: Drug: romidepsin DEP is administered at a dose of 13 mg/m2 as a 4-hour intravenous infusion in the outpa |
Active, not recruiting |
Study Name: Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma Condition:
Interventions: |